AUG 20, 2019 10:49 AM PDT

New research targets pancreatic cancer tumors' environment

New research published in the journal Nature Communications highlights the inner workings of how pancreatic cancer cells spread. Pancreatic cancer is one of the most aggressive cancers and it often metastasizes before initial detection; the average 5-year survival rate for pancreatic cancer is around just 8%.. Understanding why some pancreatic cancers metastasize is crucial for catching the cancers while treatment options are still possible.

The research was headed by Paul Timpson from the Invasion and Metastasis Laboratory at the Garvan Institute of Medical Research in Australia and Thomas Cox, who is the leader of the Matrix and Metastasis Group at the same institute.

Together, the researchers analyzed the matrix tissues from tumors in pancreatic cancers in mice that had metastasized, comparing them with the matrix tissue from tumors that had not metastasized. They focused particularly on how a certain kind of fibroblast, which generates the collagen in the matrix, interacted with pancreatic cancer cells. Using mass spectrometry, they found something surprising:

"What we discovered is a previously unknown set of matrix molecules that aggressive pancreatic cancer cells use to shape the tissue around them, in order to both protect them from chemotherapy and enable easier escape around the body," says Cox. Particularly, the study explains, the presence of perlecan, a protein that “binds several growth factors, as well as matrix components including collagen, together,” according to Medical News Today.

New research sheds light on how perlecan "educates" the environment around pancreatic cancer tumors. Photo: Pixabay

The perlecan acts as a further bad influence, explains first study author Claire Vennin. "Our results suggest that some pancreatic cancer cells can 'educate' the fibroblasts in and around the tumor. This lets the fibroblasts remodel the matrix and interact with other, less aggressive cancer cells in a way that supports the cancer cells' ability to spread," she explains. "This means that in a growing tumor, even a small number of aggressive metastatic cells — a few bad apples — can help increase the spread of other, less aggressive cancer cells."

This discovery gives scientists new insight on potential treatments for pancreatic cancer that would target perlecan. "Most cancer therapies today aim to target cancer cells themselves. The environment of tumors is a potentially untapped resource for cancer therapy and one which we intend to explore further," comments Timpson.

Sources: Medical News Today, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
SEP 22, 2020
Cardiology
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
SEP 22, 2020
Investigating the Mechanism Behind 5-Fluorouracil's Cardiotoxicity
Cancer therapies have come quite far, with several options available for many cancers. An issue that has plagued many of ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
OCT 07, 2020
Cancer
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
OCT 07, 2020
Delivering Cancer Drugs to Osteosarcoma with Nanoparticles
Over the years, cancer researchers have struggled not just with drug and diagnostic design, but with drug delivery. The ...
OCT 15, 2020
Cancer
How is mole growth really associated to skin cancer?
OCT 15, 2020
How is mole growth really associated to skin cancer?
New research published in the journal eLife questions the way we think about skin cancer. Focused on mole growth, the st ...
NOV 05, 2020
Cancer
New insights on pancreatic ductal adenocarcinoma
NOV 05, 2020
New insights on pancreatic ductal adenocarcinoma
New research published this week in Cell from scientists at NYU Grossman School of Medicine, the Department of Radi ...
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
Loading Comments...